GNH USA

Europe — EMA

Octanine (Human Coagulation Factor Ix)

GNH USA supplies Octanine (Human Coagulation Factor IX), a coagulation factor replacement therapy for hemophilia B and related bleeding disorders.

Human Coagulation Factor Ix

Request sourcing

1
Pack/s

What is Human Coagulation Factor Ix?

Human Coagulation Factor IX, the active ingredient in Octanine, is a coagulation factor replacement therapy presented as a sterile solution for intravenous use. It replaces deficient factor IX in patients with hemophilia B, helping to restore normal clotting function.

GNH USA supplies Octanine as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide through regulated supply chains, ensuring quality and traceability.

What is Human Coagulation Factor Ix used for?

Octanine is a coagulation factor replacement used in the management of hemophilia B. - Hemophilia B: provides factor IX to support clot formation and reduce bleeding episodes. - Perioperative management in hemophilia B patients: maintains hemostasis during surgical procedures. - Trauma‑related bleeding in hemophilia B: supplies factor IX to control acute bleeding events.

What are the side effects of Human Coagulation Factor Ix?

Octanine may be associated with several adverse reactions.

Common Side Effects: - Injection site pain - Fever - Headache - Nausea

Serious or Rare Side Effects: - Development of inhibitors (neutralizing antibodies) - Anaphylaxis - Thrombotic events

What precautions apply to Human Coagulation Factor Ix?

Before using Octanine, consider the following precautions. - Monitor inhibitor development: test for antibodies regularly. - Assess for allergic reactions: observe patient after infusion. - Adjust dose in renal impairment: consider renal function when dosing. - Avoid use in patients with known hypersensitivity to factor IX products. - Pregnancy considerations: weigh benefits versus potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Coagulation Factor Ix interact with?

Octanine can interact with other medicines; review the following.

Major Interactions (Avoid): - Concurrent use of anticoagulants (e.g., warfarin, direct oral anticoagulants): may reduce efficacy of factor IX. - High‑dose aspirin or NSAIDs: increase bleeding risk despite replacement therapy.

Moderate Interactions (Monitor Closely): - Live attenuated vaccines: monitor immune response after administration. - Other plasma‑derived products: risk of additive inhibitor formation. - Immunosuppressive agents: may affect inhibitor development.

Frequently asked questions

What is Octanine used for?+
Octanine is a sterile injectable containing human coagulation factor IX, used to replace deficient factor IX in patients with hemophilia B and to manage bleeding episodes, surgical procedures, and trauma‑related bleeding in this population.
How does Human Coagulation Factor IX work?+
The recombinant factor IX supplied by Octanine binds to activated factor X on platelet surfaces, restoring the intrinsic pathway of the coagulation cascade. This enables the conversion of prothrombin to thrombin, leading to fibrin clot formation and normal hemostasis in individuals lacking functional factor IX.
What is the usual dose of Octanine?+
The dose of Octanine is individualized by the prescribing clinician based on the patient’s weight, severity of deficiency, and the clinical situation (e.g., prophylaxis, on‑demand treatment, or surgery). The prescriber determines the exact units or volume to be administered intravenously.
Is Octanine safe in pregnancy or breastfeeding?+
Use of Octanine during pregnancy or lactation should be considered only when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians typically evaluate each case, and limited data are available; therefore, it is used under specialist supervision.
How do I order Octanine from GNH USA?+
To order Octanine, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed) and necessary import documentation.
How does Octanine compare with other factor IX products?+
Octanine provides recombinant human factor IX similar in efficacy to other licensed factor IX concentrates. Compared with plasma‑derived products, recombinant forms have a lower risk of viral transmission and may have different immunogenicity profiles. Choice of product depends on clinical factors, availability, and physician preference.
What are the storage requirements for Octanine?+
Octanine must be stored at 2‑8 °C (refrigerated). Keep the vials in the original packaging, protect them from light, and avoid freezing or shaking. If temperature excursions occur, discard the product according to the manufacturer’s guidelines.
How is Octanine administered?+
Octanine is given by intravenous infusion. The healthcare professional prepares the prescribed dose under aseptic conditions and administers it slowly, typically over several minutes, while monitoring the patient for any immediate adverse reactions. Dosing intervals are determined by the treating physician.
What are the most serious risks associated with Octanine?+
The most serious risks include the development of neutralizing antibodies (inhibitors) that reduce efficacy, severe allergic reactions such as anaphylaxis, and rare thrombotic events. Patients should be closely monitored for signs of inhibitor formation and hypersensitivity during and after infusion.
Who should not use Octanine?+
Octanine is contraindicated in individuals with known hypersensitivity to human factor IX or any component of the formulation. Patients with a history of severe inhibitor development or those who have experienced anaphylactic reactions to factor IX products should avoid its use unless under strict specialist supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Human Coagulation Factor Ix
Route
Intravenous Use
Manufacturer
Octapharma (Ip) Sprl
Origin
EU

Related products

Aimafix

Aimafix

Human Coagulation Factor Ix

Kedrion S.P.A.
EU
Aimafix

Aimafix

Human Coagulation Factor Ix

Kedrion S.P.A.
EU
Aimafix

Aimafix

Human Coagulation Factor Ix

Kedrion S.P.A.
EU
Alphanine

Alphanine

Human Coagulation Factor Ix

Grifols Deutschland Gmbh
EU